These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29804169)

  • 1. Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy.
    Hollin IL; Peay H; Fischer R; Janssen EM; Bridges JFP
    Qual Life Res; 2018 Sep; 27(9):2261-2273. PubMed ID: 29804169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-centered benefit-risk assessment in duchenne muscular dystrophy.
    Hollin IL; Peay HL; Apkon SD; Bridges JFP
    Muscle Nerve; 2017 May; 55(5):626-634. PubMed ID: 27649378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event.
    Bridges JFP; Tsai JH; Janssen E; Crossnohere NL; Fischer R; Peay H
    Patient; 2019 Apr; 12(2):247-257. PubMed ID: 30259384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of caregiving on women in families with Duchenne/Becker muscular dystrophy.
    Kenneson A; Bobo JK
    Health Soc Care Community; 2010 Sep; 18(5):520-8. PubMed ID: 20561071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best-worst scaling experiment in caregivers and adult patients.
    Paquin RS; Fischer R; Mansfield C; Mange B; Beaverson K; Ganot A; Martin AS; Morris C; Rensch C; Ricotti V; Russo LJ; Sadosky A; Smith EC; Peay HL
    Orphanet J Rare Dis; 2019 May; 14(1):102. PubMed ID: 31072340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial Needs and Facilitators of Mothers Caring for Children with Duchenne/Becker Muscular Dystrophy.
    Peay HL; Meiser B; Kinnett K; Tibben A
    J Genet Couns; 2018 Feb; 27(1):197-203. PubMed ID: 28803420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.
    Peay HL; Hollin I; Fischer R; Bridges JF
    Clin Ther; 2014 May; 36(5):624-37. PubMed ID: 24852596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medicine for Duchenne and Becker muscular dystrophies: characteristics of users and caregivers.
    Zhu Y; Romitti PA; Conway KM; Andrews J; Liu K; Meaney FJ; Street N; Puzhankara S; Druschel CM; Matthews DJ
    Pediatr Neurol; 2014 Jul; 51(1):71-7. PubMed ID: 24785967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived quality of life among caregivers of children with a childhood-onset dystrophinopathy: a double ABCX model of caregiver stressors and perceived resources.
    Frishman N; Conway KC; Andrews J; Oleson J; Mathews K; Ciafaloni E; Oleszek J; Lamb M; Matthews D; Paramsothy P; McKirgan L; Romitti P
    Health Qual Life Outcomes; 2017 Feb; 15(1):33. PubMed ID: 28187773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prioritizing Parental Worry Associated with Duchenne Muscular Dystrophy Using Best-Worst Scaling.
    Peay HL; Hollin IL; Bridges JF
    J Genet Couns; 2016 Apr; 25(2):305-13. PubMed ID: 26289228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labor market participation and productivity costs for female caregivers of minor male children with Duchenne and Becker muscular dystrophies.
    Soelaeman RH; Smith MG; Sahay K; Tilford JM; Goodenough D; Paramsothy P; Ouyang L; Oleszek J; Grosse SD
    Muscle Nerve; 2021 Dec; 64(6):717-725. PubMed ID: 34605048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Clinical Global Impression of Change (CGI-C) and a Caregiver Global Impression of Change (CaGI-C) measure for ambulant individuals with Duchenne muscular dystrophy.
    Staunton H; Trennery C; Arbuckle R; Guridi M; Zhuravleva E; Furlong P; Fischer R; Hall R
    Health Qual Life Outcomes; 2021 Jul; 19(1):184. PubMed ID: 34311756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is functional dependence of Duchenne muscular dystrophy patients determinant of the quality of life and burden of their caregivers?
    de Moura MC; Wutzki HC; Voos MC; Resende MB; Reed UC; Hasue RH
    Arq Neuropsiquiatr; 2015 Jan; 73(1):52-7. PubMed ID: 25608128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caregiver preferences for emerging duchenne muscular dystrophy treatments: a comparison of best-worst scaling and conjoint analysis.
    Hollin IL; Peay HL; Bridges JF
    Patient; 2015 Feb; 8(1):19-27. PubMed ID: 25523316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the barriers to cardiac care in carriers of Duchenne and Becker muscular dystrophy.
    Eekhoff L; Edwards J; Martin A; Prijoles EJ
    J Genet Couns; 2019 Oct; 28(5):993-1002. PubMed ID: 31373078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in boys with Duchenne muscular dystrophy: agreement between parents and their sons.
    Bray P; Bundy AC; Ryan MM; North KN; Everett A
    J Child Neurol; 2010 Oct; 25(10):1188-94. PubMed ID: 20179004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mothers' psychological adaptation to Duchenne/Becker muscular dystrophy.
    Peay HL; Meiser B; Kinnett K; Furlong P; Porter K; Tibben A
    Eur J Hum Genet; 2016 May; 24(5):633-7. PubMed ID: 26306645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of care for young men with Duchenne and Becker muscular dystrophy.
    Andrews JG; Davis MF; Meaney FJ
    Muscle Nerve; 2014 Jan; 49(1):21-5. PubMed ID: 23558904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deriving a Preference-Based Measure for People With Duchenne Muscular Dystrophy From the DMD-QoL.
    Rowen D; Powell P; Mukuria C; Carlton J; Norman R; Brazier J
    Value Health; 2021 Oct; 24(10):1499-1510. PubMed ID: 34593174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(40):1119-22. PubMed ID: 19834452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.